Farrukh Awan, MD
Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Division of Hematology/Oncology
Harold C. Simmons Compreshensive Cancer Center
University of Texas Southwestern Medical Center
Farrukh T. Awan, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, Bristol-Myers Squibb, Cardinal Health, Celgene, Dava Oncology, Epizyme, Genentech, Gilead Sciences, Incyte, Janssen, Johnson & Johnson, Karyopharm, Kite, MEI Pharma, Merck, Pharmacyclics, and Verastem.
Jennifer R. Brown, MD, PhD
Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Jennifer R. Brown, MD, PhD: consultant/advisor/speaker: AbbVie, Acerta, AstraZeneca, BeiGene, Bristol-Myers Squibb, Catapult, Celgene, Genentech/Roche, Hutchmed, iOnctura, Janssen, Juno, Lilly, MEI, Pharmacyclics; researcher: BeiGene, Gilead Sciences, Lilly, Loxo, MEI, SecuraBio, Sun, TG Therapeutics.
Nicole Lamanna, MD
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York
Nicole Lamanna, MD: consultant/advisor: AbbVie, AstraZeneca, BeiGene, Genentech, Janssen, Pharmacyclics; institutional researcher: AbbVie, AstraZeneca, BeiGene, Genentech, Loxo/Lilly, MingSight, Octapharma, Oncternal, TG Therapeutics.
Anthony Mato, MD, MSCE
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York
Anthony Mato, MD, MSCE, has disclosed that he has received funds for research support from AbbVie, Acerta/AstraZeneca, Adaptive, DTRM BioPharma, Johnson & Johnson, Loxo Oncology, Nurix, Genmab, Pharmacyclics, Regeneron, Sunesis, and TG Therapeutics and has received consulting fees from AbbVie, Acerta/AstraZeneca, Adaptive, Celgene, DTRM BioPharma, Johnson & Johnson, Nurix, Genmab, LOXO, Genentech, AZ, Pharmacyclics, Sunesis, TG Therapeutics, and Verastem.
Jeffrey P. Sharman, MD
Willamette Valley Cancer Institute
Jeffrey P. Sharman, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, Janssen, Lilly, Merck.
This program has been made available online.